Cornea/External Disease News

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Preeya K. Gupta, MD, discusses Vevye’s positive impact on the signs and symptoms of dry eye disease.

Ophthalmologists must work with oncologists to understand and mitigate ocular surface adverse events caused by oncologic therapeutics, according to a presentation at Real World Ophthalmology.

Ever heard of a helical collagen intercalator? How about a TRPM8 agonist? Maybe RASP as a target of treatment?

When a young patient presents with atypical refractive findings and an inability to see 20/20 in one eye, that eye is often labeled “amblyopic.”

Penetrating keratoplasty is an effective procedure that can restore sight for patients. However, it is not without significant risks and burdens, especially for young people who may need a second or even third graft during their lifetime.

Re-esterified triglyceride omega-3 fatty acid supplementation did not improve symptoms of dry eye disease associated with meibomian gland dysfunction in a small cohort of patients, according to research published in JAMA Ophthalmology.

EyeCRO announced that its Microemulsion Drug Ocular Penetration System, or MiDROPS, demonstrated safety and efficacy in its first clinical application as a topical eye drop vehicle for dry eye disease.

Ophthalmologists can attend interactive sessions, network with colleagues and earn CME credits at this year’s Kiawah Eye, organized by Healio Live.

NovaBay Pharmaceuticals has launched an expanded line of Avenova product bundles to provide personalized treatment options beyond artificial tears for patients with dry eye disease.

Researchers found no significant differences in keratometry measurements before cataract surgery among patients with dry eye disease vs. those without, according to a study conducted in Norway and published in Clinical Ophthalmology.